Chlorothiazide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlorothiazide and what is the scope of patent protection?
Chlorothiazide
is the generic ingredient in eleven branded drugs marketed by Salix Pharms, Abc Holding, Hikma Intl Pharms, Lederle, Norvium Bioscience, Sandoz, Watson Labs, Rising, Am Regent, Fresenius Kabi Usa, Rk Pharma, Sagent Pharms Inc, Sun Pharm, Merck, Par Pharm, and Hikma, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.There are forty-two drug master file entries for chlorothiazide. One supplier is listed for this compound.
Summary for chlorothiazide
US Patents: | 0 |
Tradenames: | 11 |
Applicants: | 16 |
NDAs: | 29 |
Drug Master File Entries: | 42 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 8 |
Patent Applications: | 7,019 |
Drug Prices: | Drug price trends for chlorothiazide |
What excipients (inactive ingredients) are in chlorothiazide? | chlorothiazide excipients list |
DailyMed Link: | chlorothiazide at DailyMed |
Recent Clinical Trials for chlorothiazide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Virginia | Phase 4 |
Vanderbilt University | Phase 4 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
Pharmacology for chlorothiazide
Drug Class | Thiazide Diuretic |
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for chlorothiazide
Anatomical Therapeutic Chemical (ATC) Classes for chlorothiazide
US Patents and Regulatory Information for chlorothiazide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | CHLOROTHIAZIDE | chlorothiazide | TABLET;ORAL | 086796-001 | Aug 15, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rising | DIURIL | chlorothiazide | TABLET;ORAL | 011145-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | DIUPRES-250 | chlorothiazide; reserpine | TABLET;ORAL | 011635-003 | Aug 26, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | ALDOCLOR-150 | chlorothiazide; methyldopa | TABLET;ORAL | 016016-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.